These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7690181

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Characterization of major surface and excretory-secretory immunogens of Trypanosoma cruzi trypomastigotes and identification of potential protective antigen.
    Ouaissi MA, Taibi A, Cornette J, Velge P, Marty B, Loyens M, Esteva M, Rizvi FS, Capron A.
    Parasitology; 1990 Feb; 100 Pt 1():115-24. PubMed ID: 2107503
    [Abstract] [Full Text] [Related]

  • 5. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
    Gazzinelli RT, Galvao LM, Krautz G, Lima PC, Cancado JR, Scharfstein J, Krettli AU.
    Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Galactofuranose-containing glycoconjugates of epimastigote and trypomastigote forms of Trypanosoma cruzi.
    Golgher DB, Colli W, Souto-Padrón T, Zingales B.
    Mol Biochem Parasitol; 1993 Aug; 60(2):249-64. PubMed ID: 8232416
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Partial inhibition of trypomastigote entry into cultured mammalian cells by monoclonal antibodies against a surface glycoprotein of Trypanosoma cruzi.
    Alves MJ, Abuin G, Kuwajima VY, Colli W.
    Mol Biochem Parasitol; 1986 Oct; 21(1):75-82. PubMed ID: 3534565
    [Abstract] [Full Text] [Related]

  • 15. Altering the motility of Trypanosoma cruzi with rabbit polyclonal anti-peptide antibodies reduces infection to susceptible mammalian cells.
    Finkelsztein EJ, Diaz-Soto JC, Vargas-Zambrano JC, Suesca E, Guzmán F, López MC, Thomas MC, Forero-Shelton M, Cuellar A, Puerta CJ, González JM.
    Exp Parasitol; 2015 Mar; 150():36-43. PubMed ID: 25633439
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Trypanosoma cruzi: immunity-induced in mice and rats by trypomastigote excretory-secretory antigens and identification of a peptide sequence containing a T cell epitope with protective activity.
    Taibi A, Plumas-Marty B, Guevara-Espinoza A, Schöneck R, Pessoa H, Loyens M, Piras R, Aguirre T, Gras-Masse H, Bossus M.
    J Immunol; 1993 Sep 01; 151(5):2676-89. PubMed ID: 7689612
    [Abstract] [Full Text] [Related]

  • 18. Identification of immunodominant epitopes in Trypanosoma cruzi trypomastigote surface antigen-1 protein that mask protective epitopes.
    Wrightsman RA, Dawson BD, Fouts DL, Manning JE.
    J Immunol; 1994 Oct 01; 153(7):3148-54. PubMed ID: 7522250
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.